・The analyst noted that sponsors must continue producing study data to suggest psychedelics can safely produce profound efficacy in mental health. ・Jefferies added that it believes Atai Beckley's ...

Cathie Wood is loading up on shares of a biotech that could be one of the first entrants to the psychedelics market.

Atai Life Sciences' BPL-003 showed robust, rapid, and durable antidepressant effects in Phase 2b TRD data, spiking shares over 20%. BPL-003's short clinic time and strong efficacy could fit existing ...

Twelve years ago, Christian Angermayer took a mushroom trip that inspired him to try to create FDA-approved medicines from psychedelic drugs. Now Big Pharma is making a $2.8 billion bet on his vision.

Editor’s Note: This story has been updated to correct an error regarding ATAI’s stock price movement. AtaiBeckley Inc. ATAI shares are trending on Thursday. Lilly Eyes Acquisition At A Premium Shares ...

Atai Life Sciences N.V. ( (ATAI)) has released its Q3 earnings. Here is a breakdown of the information Atai Life Sciences N.V. presented to its investors. Atai Life Sciences N.V. is a clinical-stage ...

Lilly's purchase of AtaiBeckley is yet another strategic move in its bid to diversify its pipeline.

NEW YORK and BERLIN, Jan. 10, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental ...

Atai Life Sciences, the Peter Thiel-backed start-up that wants to use psychedelic drugs to treat mental health conditions, has increased its stake in fellow drug developer Compass Pathways. Stream San ...

NEW YORK and BERLIN, Jan. 04, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental ...

Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds. Standing on the shoulders of Johnson & Johnson's Spravato. Upcoming ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Atai Life Sciences N.V. (NASDAQ:ATAI) stands against the other ...